Related Experiment Video
Updated: May 5, 2026
07:32
Assessment of Vascular Regeneration in the CNS Using the Mouse Retina
Published on: June 23, 2014
14.4K
Alpha-Melanocyte-Stimulating Hormone Maintains Retinal Homeostasis after Ischemia/Reperfusion
Tat Fong Ng1, Jenna Y Cho1, John L Zhao1
1Department of Ophthalmology, Boston University Chobanian & Avedesian School of Medicine, Boston, MA 02118, USA.
Biomolecules
|May 24, 2024
Summary
Therapeutic alpha-melanocyte-stimulating hormone (α-MSH) protects the retina from degeneration by reducing cell death and preserving structure in an ischemia-reperfusion injury model, highlighting its potential for treating retinal diseases.
Area of Science:
- Ophthalmology
- Neuroscience
- Cell Biology
Background:
- The melanocortin pathway plays a role in retinal protection against degeneration.
- Oxidative stress and apoptosis contribute to retinal cell death in various eye diseases.
Purpose of the Study:
- To investigate the therapeutic potential of alpha-melanocyte-stimulating hormone (α-MSH) in an experimental model of retinal degenerative disease.
- To evaluate the effects of α-MSH on retinal structure and cell survival following ischemia-reperfusion (I/R) injury.
Main Methods:
- An ischemia and reperfusion (I/R) procedure was performed on mouse eyes.
- Eyes were treated with α-MSH, and retinal sections were analyzed histopathologically.
- Immunohistochemistry was used to assess ganglion cells, Muller cells, microglial cells, and apoptosis.
Main Results:
- I/R induced retinal deformation and ganglion cell loss, which were significantly reduced by α-MSH treatment.
- α-MSH treatment suppressed microglial activation and reduced apoptosis in the neuroretina.
- Muller cell activation was marginally affected by α-MSH.
Conclusions:
- Therapeutic augmentation of melanocortin pathways with α-MSH preserves retinal structure and cell survival.
- α-MSH demonstrates neuroprotective effects in a model of progressive retinal degenerative disease.
- This suggests a potential therapeutic strategy for various retinal conditions involving I/R injury.
Related Concept Videos
01:10Mechanism of Angiogenesis
6.4K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
6.4K
01:24Regulation of Angiogenesis and Blood Supply
2.9K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.9K
01:16Vascular Spasm
4.9K
The vascular phase, also known as vasospasm, is the initial stage of hemostasis, crucial for preventing excessive bleeding when a blood vessel is injured. After a vessel is cut, nerves in the damaged area trigger pain and other sensory impulses. Simultaneously, the smooth muscles in the vessel wall contract, resulting in a vascular spasm. This contraction reduces the vessel's diameter at the injury site, slowing or stopping blood loss through the vessel wall. Vascular spasms typically last...
4.9K
01:22Formation of the Platelet Plug
6.2K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
6.2K
01:16Clot Retraction and Fibrinolysis
6.0K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
6.0K
01:17Autoregulation of Blood Flow
10.0K
Autoregulation mechanisms are characterized by their inherent capacity for self-regulation without necessitating specific nervous stimulation or endocrine control. These mechanisms facilitate the adjustment of blood flow and, therefore, perfusion specific to each tissue region. This self-regulation encompasses chemical signals and myogenic controls.
Chemical Signaling in Autoregulation
Chemical signaling operates at the precapillary sphincter level, inciting either contraction or relaxation....
Chemical Signaling in Autoregulation
Chemical signaling operates at the precapillary sphincter level, inciting either contraction or relaxation....
10.0K